Advertisement
BIOLASE Promotes Jennifer Bright To CFO, Steven Sandor To COO
(RTTNews) - Medical device company BIOLASE, Inc. (BIOL) announced Thursday the appointments of Jennifer Bright to Chief Financial Officer and Steven Sandor to Chief Operating Officer. These promotions are effective immediately, and the positions will report to John Beaver, BIOLASE's President and Chief Executive Officer.
Bright has served as the company's Vice President of Finance since April 2021. Her responsibilities as CFO will include the functional areas of finance, accounting, investor relations, and assisting the executive management team in establishing long-range goals, strategies, plans and policies that drive positive results. She began her career at PricewaterhouseCoopers.
Meanwhile, Sandor joined BIOLASE in early 2019 and has served in several impactful positions in its customer-facing organizations, most recently as the company's Senior Director of Commercial Operations and Service.
Sandor has been instrumental in developing long-term strategic growth initiatives focused on leveraging talent, building robust commercial processes, and scalability.
U.S. Labor Productivity Rebounds Roughly In Line With Estimates In Q2
U.S. Jobless Claims Rise More Than Expected To 226,000
Bank Of England Cuts Rate In Tight Vote
Global Cues, Firm Commodity Prices Point To Another Firm Start On Bay Street
U.S. Labor Productivity Surges 2.4% In Second Quarter
U.S. Weekly Jobless Claims Rise More Than Expected
Pound Jumps After BoE Rate Decision
